Biological Evaluation of Structurally Diverse Amaryllidaceae Alkaloids and their Synthetic Derivatives: Discovery of Novel Leads for Anticancer Drug Design
- 23 February 2009
- journal article
- research article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 75 (05), 501-507
- https://doi.org/10.1055/s-0029-1185340
Abstract
Twenty-nine Amaryllidaceae alkaloids and their derivatives belonging to the five most common groups, including lycorine, lycorenine, tazettine, crinine, and narciclasine types, were evaluated for antiproliferative, apoptosis–inducing, and anti-invasive activities in vitro. The antiproliferative properties of each test compound are in agreement with those reported in the literature, while the high potency of amarbellisine is reported for the first time. It was also found that with the exception of ungeremine, amarbellisine, and hippeastrine, the antiproliferative effect of the potent compounds is apoptosis mediated. Thus, apoptosis in Jurkat cells was triggered by narciclasine, narciclasine tetraacetate, C10b-R-hydroxypancratistatin, cis-dihydronarciclasine, trans-dihydronarciclasine, lycorine, 1-O-acetyllycorine, lycorine-2-one, pseudolycorine, and haemanthamine. With the exception of narciclasine, lycorine, and haemanthamine, the apoptosis-inducing properties of these compounds are reported for the first time. The collagen type I invasion assay revealed potent anti-invasive properties associated with N-methyllycorine iodide, hippeastrine, clivimine, buphanamine, and narciclasine tetraacetate, all of which were tested at non-toxic concentrations. The anti-invasive activity of buphanamine is particularly promising because this alkaloid is not toxic to cells even at much higher doses. This work has resulted in the identification of several novel leads for anticancer drug design.Keywords
This publication has 34 references indexed in Scilit:
- Chemistry, Biology, and Medicinal Potential of Narciclasine and its CongenersChemical Reviews, 2008
- Effects of lycorine on HL‐60 cells via arresting cell cycle and inducing apoptosisFEBS Letters, 2004
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Antiproliferative Amaryllidaceae Alkaloids Isolated from the Bulbs of Sprekelia formosissima and Hymenocallis × festalisPlanta Medica, 2002
- Two New Alkaloids of the Crinane Series from Pancratium sickenbergeriPlanta Medica, 2002
- Anti-invasion drugsBreast Cancer Research and Treatment, 1996
- Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor roleCell, 1991
- Narciclasine:1H- and13C-NMR Data and a New Improved Method of PreparationPlanta Medica, 1991
- Location of resistance to the alkaloid narciclasine in the 60S ribosomal subunitFEBS Letters, 1975
- Narciclasine: an antitumour alkaloid which blocks peptide bond formation by eukaryotic ribosomesFEBS Letters, 1975